Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability (vol 17, pg 895, 2007)

被引：1
|
作者：
Yu, Kuo-Long
Sin, Ny
Civiello, Rita L.
Wang, X. Alan
Combrink, Keith D.
Gulgeze, H. Belgin
Venables, Brian L.
Wright, J. J. Kim
Dalterio, Richard A.
Zadjura, Lisa
Marino, Anthony
Dando, Sandra
D'Arienzo, Celia
Kadow, Kathleen F.
Cianci, Christopher W.
Li, Zhufang
Clarke, Junius
Genovesi, Eugene V.
Medina, Ivette
Lamb, Lucinda
Colonno, Richard J.
Yang, Zheng
Krystal, Mark
Meanwell, Nicholas A.
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Chem, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Analyt Sci, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Wallingford, CT 06492 USA
[4] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Princeton, NJ 08543 USA
[5] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Virol, Wallingford, CT 06492 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 08期
关键词：
D O I：
10.1016/j.bmcl.2007.03.020
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2385 / 2385
页数：1
相关论文
共 23 条
  • [1] Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability
    Yu, Kuo-Long
    Sin, Ny
    Civiello, Rita L.
    Wang, X. Alan
    Combrink, Keith D.
    Gulgeze, H. Belgin
    Venables, Brian L.
    Wright, J. J. Kim
    Dalterio, Richard A.
    Zadjura, Lisa
    Marino, Anthony
    Dando, Sandra
    D'Arienzo, Celia
    Kadow, Kathleen F.
    Cianci, Christopher W.
    Li, Zhufang
    Clarke, Junius
    Genovesi, Eugene V.
    Medina, Ivette
    Lamb, Lucinda
    Colonno, Richard J.
    Yang, Zheng
    Krystal, Mark
    Meanwell, Nicholas A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (04) : 895 - 901
  • [2] Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity
    Wang, Xiangdong Alan
    Cianci, Christopher W.
    Yu, Kuo-Long
    Combrink, Keith D.
    Thuring, Jan W.
    Zhang, Yi
    Civiello, Rita L.
    Kadow, Kathleen F.
    Roach, Julia
    Li, Zhufang
    Langley, David R.
    Krystal, Mark
    Meanwell, Nicholas A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4592 - 4598
  • [3] Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives
    Yu, KL
    Zhang, Y
    Civiello, RL
    Trehan, AK
    Pearce, BC
    Yin, ZW
    Combrink, KD
    Gulgeze, HB
    Wang, XDA
    Kadow, KF
    Cianci, CW
    Krystal, M
    Meanwell, NA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) : 1133 - 1137
  • [4] Respiratory syncytial virus - the discovery and optimization of orally bioavailable fusion inhibitors
    Meanwell, Nicholas A.
    Krystal, Mark
    DRUGS OF THE FUTURE, 2007, 32 (05) : 441 - 455
  • [5] Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety
    Combrink, Keith D.
    Gulgeze, H. Belgin
    Thuring, Jan W.
    Yu, Kuo-Long
    Civiello, Rita L.
    Zhang, Yi
    Pearce, Bradley C.
    Yin, Zhiwei
    Langley, David R.
    Kadow, Kathleen F.
    Cianci, Christopher W.
    Li, Zhufang
    Clarke, Junius
    Genovesi, Eugene V.
    Medina, Ivette
    Lamb, Lucinda
    Yang, Zheng
    Zadjura, Lisa
    Krystal, Mark
    Meanwell, Nicholas A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (17) : 4784 - 4790
  • [6] Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo
    Yu, KL
    Wang, XDA
    Civiello, RL
    Trehan, AK
    Pearce, BC
    Yin, ZW
    Combrink, KD
    Gulgeze, HB
    Zhang, Y
    Kadow, KF
    Cianci, CW
    Clarke, J
    Genovesi, EV
    Medina, I
    Lamb, L
    Wyde, PR
    Krystal, M
    Meanwell, NA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (05) : 1115 - 1122
  • [7] Respiratory syncytial virus fusion inhibitors. Part 7: Structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo
    Sin, Ny
    Venables, Brian L.
    Combrink, Keith D.
    Gulgeze, H. Belgin
    Yu, Kuo-Long
    Civiello, Rita L.
    Thuring, Jan
    Wang, X. Alan
    Yang, Zheng
    Zadjura, Lisa
    Marino, Anthony
    Kadow, Kathleen F.
    Cianci, Christopher W.
    Clarke, Junius
    Genovesi, Eugene V.
    Medina, Ivette
    Lamb, Lucinda
    Krystal, Mark
    Meanwell, Nicholas A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4857 - 4862
  • [8] Influenza and respiratory syncytial virus-associated mortality and hospitalisations (vol 30, pg 1158, 2007)
    Jansen, A. G. S. C.
    Sanders, E. A. M.
    Hoes, A. W.
    Van Loon, A. M.
    Hak, E.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (03) : 691 - 691
  • [9] Inhibitors of respiratory syncytial virus fusion: Optimization from screening leads to potent, orally active compounds
    Meanwell, Nicholas A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [10] Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus (vol 342, pg 592, 2013)
    McLellan, J. S.
    SCIENCE, 2013, 342 (6161) : 931 - 931
123